TY - JOUR
T1 - Opening Pandoras jar
T2 - A primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders
AU - Khanna, Rajesh
AU - Wilson, Sarah M.
AU - Brittain, Joel M.
AU - Weimer, Jill
AU - Sultana, Rukhsana
AU - Butterfield, Allan
AU - Hensley, Kenneth
PY - 2012/11
Y1 - 2012/11
N2 - CRMP2, also known as DPYSL2/DRP2, Unc-33, Ulip or TUC2, is a cytosolic phosphoprotein that mediates axon/dendrite specification and axonal growth. Mapping the CRMP2 interactome has revealed previously unappreciated functions subserved by this protein. Together with its canonical roles in neurite growth and retraction and kinesin-dependent axonal transport, it is now known that CRMP2 interacts with numerous binding partners to affect microtubule dynamics; protein endocytosis and vesicular cycling, synaptic assembly, calcium channel regulation and neurotransmitter release. CRMP2 signaling is regulated by post-translational modifications, including glycosylation, oxidation, proteolysis and phosphorylation; the latter being a fulcrum of CRMP2 functions. Here, the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders are discussed and evidence is presented for therapeutic strategies targeting CRMP2 functions.
AB - CRMP2, also known as DPYSL2/DRP2, Unc-33, Ulip or TUC2, is a cytosolic phosphoprotein that mediates axon/dendrite specification and axonal growth. Mapping the CRMP2 interactome has revealed previously unappreciated functions subserved by this protein. Together with its canonical roles in neurite growth and retraction and kinesin-dependent axonal transport, it is now known that CRMP2 interacts with numerous binding partners to affect microtubule dynamics; protein endocytosis and vesicular cycling, synaptic assembly, calcium channel regulation and neurotransmitter release. CRMP2 signaling is regulated by post-translational modifications, including glycosylation, oxidation, proteolysis and phosphorylation; the latter being a fulcrum of CRMP2 functions. Here, the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders are discussed and evidence is presented for therapeutic strategies targeting CRMP2 functions.
KW - Alzheimers disease
KW - CRMP2
KW - CRMP2 hyperphosphorylation
KW - CRMP2/CLN6/KLC4 signaling complex
KW - amyotrophic lateral sclerosis
KW - axon elongation
KW - excitotoxicity
KW - multiple sclerosis
KW - neuropathic pain
KW - oxidative damage
UR - http://www.scopus.com/inward/record.url?scp=84868642241&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84868642241&partnerID=8YFLogxK
U2 - 10.2217/fnl.12.68
DO - 10.2217/fnl.12.68
M3 - Review article
AN - SCOPUS:84868642241
SN - 1479-6708
VL - 7
SP - 749
EP - 771
JO - Future Neurology
JF - Future Neurology
IS - 6
ER -